Tommy Kenny
Consigliere Generale presso INTELGENX TECHNOLOGIES CORP.
Patrimonio netto: 27 931 $ in data 30/04/2024
Profilo
Tommy Kenny has held multiple positions in the legal field.
He is currently the Vice President-Legal Affairs & General Counsel at Intelgenx Corp.
and has been in this role since 2021.
Prior to this, he served as the Senior Vice President & General Counsel at IntelGenx Technologies Corp.
starting in 2016.
Additionally, Mr. Kenny currently works as an Associate at Brouillette & Partners.
In terms of education, Mr. Kenny holds a graduate degree from the University of Sherbrooke and a undergraduate degree from Bishop's University.
He also obtained a graduate degree from the University of Montreal Law School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
29/01/2024 | 167 250 ( 0.10% ) | 27 931 $ | 30/04/2024 |
Posizioni attive di Tommy Kenny
Società | Posizione | Inizio |
---|---|---|
INTELGENX TECHNOLOGIES CORP. | Consigliere Generale | 01/01/2016 |
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Consigliere Generale | 01/01/2021 |
Brouillette & Partners | Corporate Officer/Principal | - |
Formazione di Tommy Kenny
University of Montreal Law School | Graduate Degree |
University of Sherbrooke | Graduate Degree |
Bishop's University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
INTELGENX TECHNOLOGIES CORP. | Health Technology |
Aziende private | 2 |
---|---|
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
Brouillette & Partners |
- Borsa valori
- Insiders
- Tommy Kenny